Invention Grant
US08691943B2 Antimicrobial activity of chicken NK-2 peptide against apicomplexan protozoa
有权
鸡NK-2肽对apicomplexan原生动物的抗菌活性
- Patent Title: Antimicrobial activity of chicken NK-2 peptide against apicomplexan protozoa
- Patent Title (中): 鸡NK-2肽对apicomplexan原生动物的抗菌活性
-
Application No.: US13071112Application Date: 2011-03-24
-
Publication No.: US08691943B2Publication Date: 2014-04-08
- Inventor: Hyun Soon Lillehoj , Sung Hyen Lee , Yeong ho Hong
- Applicant: Hyun Soon Lillehoj , Sung Hyen Lee , Yeong ho Hong
- Applicant Address: US DC Washington
- Assignee: The United States of America, as represented by the Secretary of Agriculture
- Current Assignee: The United States of America, as represented by the Secretary of Agriculture
- Current Assignee Address: US DC Washington
- Agent John D. Fado; Evelyn M. Rabin
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K5/00 ; C07K7/00 ; C07K16/00 ; C07K17/00 ; A61K38/04 ; C07K1/00 ; A01N37/18 ; A61P33/02 ; A61K51/00

Abstract:
NK-2 synthetic peptide derived from cationic core region of porcine NK-lysin has an antimicrobial and antitumor polypeptide that is considered to play a pivotal role in innate defense immunity. To evaluate the antimicrobial properties of synthetic chicken NK-lysin peptides, we investigated cytolytic activity against apicomplexan parasites like Eimeria sporozoites, Neospora tachyzoites and Cryptosporidum sporozoites. The chicken NK-2 (cNK-2) lytic peptide which corresponds to amino acid residues of porcine NK-2 peptide significantly disrupted Eimeria and Cryptosporidum sporozoites and Neospora tachyzoites. In contrast, no bactericidal activity was observed on E. coli BMH71-18. The cNK-2 lytic peptide is novel antimicrobial agent which can be used to intervene and treat economically costly infections in the animal industry.
Public/Granted literature
- US20120245082A1 Novel Antimicrobial Activity of Chicken NK-2 Peptide Against Apicomplexan Protozoa Public/Granted day:2012-09-27
Information query
IPC分类: